AI in Healthcare

What happens when AI in healthcare meets a regulatory gray zone? The HHS plan to allow compounding pharmacies to produce unapproved peptides—without FDA validation—exposes a critical flaw: AI models trained on approved data cannot assess risks from unregulated substances. This isn’t just a policy gap; it’s a systemic blind spot in AI’s ability to protect patients. The source: STAT News, October 16, 2026. https://www.statnews.com/pharmalot/2026/10/16/hhs-peptide-push-trump-pharma-stock-holdings/. How can AI be trusted to vet treatments it wasn’t trained to recognize? Let’s discuss the real cost of data bias in medical AI. Source: https://www.statnews.com/pharmalot/2026/10/16/hhs-peptide-push-trump-pharma-stock-holdings/ View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III, MPA Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC dba ALEX.realestate, et.al. Texas License #574878-B · Broker License #565194-BB Broker, ALEX Real Estate · North Carolina License #367733 Independent Broker, ALEX Real Estate · Colorado License #II.100112456 [email protected] · +1 713.918.9951